These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29129120)

  • 1. Successful treatment of HIV-/HCV-coinfected patients in the era of direct acting antivirals: is advanced liver disease still a limiting factor?
    Gonzales Zamora JA
    Infect Dis (Lond); 2018 Apr; 50(4):320-323. PubMed ID: 29129120
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial commentary: Management of hepatitis C Virus in HIV-infected patients in the era of direct-acting antivirals.
    Zeremski M; Martinez AD; Talal AH
    Clin Infect Dis; 2014 Mar; 58(6):880-2. PubMed ID: 24336913
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of acute and chronic HCV infection in persons with HIV coinfection.
    Sulkowski MS
    J Hepatol; 2014 Nov; 61(1 Suppl):S108-19. PubMed ID: 25443339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
    Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
    AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals.
    Hasson H; Merli M; Messina E; Bhoori S; Salpietro S; Morsica G; Regalia E; Bagaglio S; Lazzarin A; Uberti-Foppa C; Mazzaferro V
    J Hepatol; 2017 Aug; 67(2):415-417. PubMed ID: 28411040
    [No Abstract]   [Full Text] [Related]  

  • 6. Late presentation of chronic hepatitis C patients in the era of direct-acting antivirals-Data from the German Hepatitis C-Registry.
    Bischoff J; Mauss S; Lutz T; Cordes C; Klausen G; Scholten S; Hillenbrand H; Cornberg M; Baumgarten A; Rockstroh JK;
    J Viral Hepat; 2021 Nov; 28(11):1660-1664. PubMed ID: 34289197
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug Interactions.
    Chan J; Chung RT
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):147-163. PubMed ID: 28263458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.
    Rockstroh JK
    Liver Int; 2015 Jan; 35 Suppl 1():51-5. PubMed ID: 25529087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant Treatment of Hepatitis C Virus and Diffuse Large B-Cell Lymphoma with Direct-Acting Antivirals in HIV Coinfection: A Case Report.
    Gallipani A; Cha A; Berkowitz L; Bakshi A
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218822062. PubMed ID: 30798652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV-HIV co-infected patients: no longer a 'special' population?
    Sulkowski MS
    Liver Int; 2016 Jan; 36 Suppl 1():43-6. PubMed ID: 26725896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.
    Sanmartín R; Tor J; Sanvisens A; López JJ; Jou A; Muga R; Ojanguren I; Barluenga E; Videla S; Planas R; Clotet B; Tural C
    HIV Med; 2014 Apr; 15(4):203-12. PubMed ID: 24245909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms.
    Cooper CL; Klein MB
    HIV Med; 2014 Nov; 15(10):621-4. PubMed ID: 24802099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies.
    Labarga P; Fernández-Montero JV; López M; Barreiro P; de Mendoza C; Sierra-Enguita R; Treviño A; Soriano V
    Antivir Ther; 2014; 19(8):799-803. PubMed ID: 24964405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in hepatitis C treatment initiation among HIV/hepatitis C virus-coinfected men engaged in primary care in a multisite community health centre in Maryland: a retrospective cohort study.
    Chen YC; Thio CL; Cox AL; Ruhs S; Kamangar F; Wiberg KJ
    BMJ Open; 2019 Mar; 9(3):e027411. PubMed ID: 30928964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV-HCV-coinfected individuals.
    Klein MB; Rollet KC; Hull M; Cooper C; Walmsley S; Conway B; Pick N;
    Antivir Ther; 2013; 18(5):717-21. PubMed ID: 23211632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.
    Soriano V; Labarga P; Vispo E; Fernández-Montero JV; Barreiro P
    Infect Dis Clin North Am; 2012 Dec; 26(4):931-48. PubMed ID: 23083825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The importance of renal function monitoring for the use of Direct-Action Antivirals in patients coinfected with HIV/HCV].
    Orihuela Casimiro AI; Pérez Caballero MN
    Rev Gastroenterol Peru; 2022; 42(4):264-265. PubMed ID: 36746469
    [No Abstract]   [Full Text] [Related]  

  • 18. Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
    Bruno R; Fagiuoli S; Sacchi P
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):699-701. PubMed ID: 21905777
    [No Abstract]   [Full Text] [Related]  

  • 19. [Answer to the letter: The importance of renal function monitoring for the use of Direct-Action Antivirals in patients coinfected with HIV/HCV].
    Collins-Camones JA; Chamorro-Chirinos ER; Loyola-Salvatierra FV
    Rev Gastroenterol Peru; 2023; 43(1):77-78. PubMed ID: 37226076
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals.
    Rohrbach J; Stickel F; Schmid P; Thormann W; Kovari H; Scherrer A; Günthard HF; Vuichard D; Cavassini M; Ambrosioni J; Bernasconi E; Furrer H; Rauch A;
    Antivir Ther; 2014; 19(2):149-59. PubMed ID: 24036684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.